We explored the role of CD18 (beta2 integrin) in platelet physiology, using
mice genetically deficient in CD18 (CD18 -/-), or its main ligand CD54 (IC
AM-1, CD54 -/-). CD18 and CD11a were evident in platelets from +/+, but not
from CD18 -/- mice, as seen by immunofluorescence or Western blots. CD18 m
RNA was also detectable by RT-PCR in platelets from +/+, but not from CD18
-/- mice. The life span of platelets was significantly shorter in CD18 -/-
than in +/+ or CD54 -/- mice, as seen by in vivo biotinylation. When a loca
l inflammation was elicited by the intra-tracheal injection of TNF, labeled
platelets from +/+, but not from CD18 -/- donors, did localize in the lung
. The content of Bcl-3 was about 20-fold higher in platelet from CD18 -/-,t
han in those from +/+ or CD54 -/- donors, as seen on Western blots or by im
munofluorescence and flow cytometry, while the amount of pro-caspase-3 was
decreased. An activation of caspases in platelets from CD18 -/- was also ev
idenced by protease assays. Accordingly, gelsolin, a protein cleaved by cas
pase-3, showed a low-molecular-weight band in platelets from CD18 -/- but n
ot from +/+ donors. These results demonstrate that the beta2 integrin, pres
ent in mouse platelets, modulates caspase activation and consequently plate
let life span and response to TNF.